Empery Asset Management, LP Benitec Biopharma Inc. Transaction History

Empery Asset Management, LP

  • $16.8 Million
  • Q3 2022

A detailed history of Empery Asset Management, LP transactions in Benitec Biopharma Inc. stock. As of the latest transaction made, Empery Asset Management, LP holds 796,837 shares of BNTC stock, worth $8.37 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares
796,837
Holding current value
$8.37 Million
% of portfolio
1.76%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.31 - $6.32 $247,019 - $5.04 Million
796,837 New
796,837 $296,000

Others Institutions Holding BNTC

# of Institutions
3
Shares Held
1.42M
Call Options Held
0
Put Options Held
0
View Full List

About Benitec Biopharma Inc.

BNTC Quotes by TradingView
  • Ticker BNTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,809,500
  • Market Cap $271M
  • Description
  • Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...
More about BNTC
Track This Portfolio

Track Empery Asset Management, LP Portfolio

Follow Empery Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empery Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Empery Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email